Neurotrophic tacrolimus analogs

Details for Australian Patent Application No. 2002231277 (hide)

Owner Astellas Pharma, Inc.

Inventors Yamaji, Takayuki; Matsuoka, Nobuya; Gold, Bruce

Agent Davies Collison Cave

Pub. Number AU-B-2002231277

PCT Pub. Number WO2002/053159

Priority 60/258,500 29.12.00 US

Filing date 31 December 2001

Wipo publication date 16 July 2002

Acceptance publication date 30 November 2006

International Classifications

A61K 31/44 (2006.01) - Non-condensed pyridines

Event Publications

23 January 2003 Application Open to Public Inspection

  Published as AU-B-2002231277

2 February 2006 Change of Name(s) of Applicant(s), Section 104

  Fujisawa Pharmaceutical Co., Ltd. The name of the applicant has been changed to Astellas Pharma, Inc.

30 November 2006 Application Accepted

  Published as AU-B-2002231277

29 March 2007 Standard Patent Sealed

23 July 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002231278

2002231276-POLYPODAL CHELANTS FOR METALLOPHARMACEUTICALS